Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo

    May 2019 in “ JAMA Dermatology ”
    Ji Hae Lee, Hyuck Sun Kwon, Han Mi Jung … Jung Min Bae
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on jamanetwork.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Treatment of Vitiligo with the Topical Janus Kinase Inhibitor Ruxolitinib: A 32-Week Open-Label Extension Study with Optional Narrow-Band Ultraviolet B Journal of the American Academy of Dermatology · 2018
    2. Pimecrolimus Increases the Melanogenesis and Migration of Melanocytes In Vitro Korean Journal of Physiology and Pharmacology · 2017
    3. Guidelines for the Management of Vitiligo: The European Dermatology Forum Consensus British Journal of Dermatology · 2013
    4. Vitiligo: A Comprehensive Overview Journal of the American Academy of Dermatology · 2011
    5. Variations of Hair Follicle Size and Distribution in Different Body Sites Journal of Investigative Dermatology · 2004